#drug-pricing-policy

[ follow ]
#healthcare-sector #abbvie #ma-activity #glp-1-weight-loss-drugs #tariff-concessions
Healthcare
from24/7 Wall St.
3 days ago

This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence

Healthcare shows signs of stabilization and potential rebound driven by easing policy risks, clearer earnings, and increased M&A, with AbbVie as a dividend-led candidate.
US politics
fromwww.dw.com
1 month ago

Trump unveils deals to lower prices of weight loss drugs DW 11/07/2025

The Trump administration secured discounts from Eli Lilly and Novo Nordisk for GLP-1 weight-loss drugs in exchange for tariff relief to reduce US drug costs.
Medicine
from24/7 Wall St.
1 month ago

Is Trump Going to Kill the GLP-1 Cash Cow?

GLP-1 obesity and diabetes drugs produced massive profits for Novo Nordisk and Eli Lilly, funding factory expansions while political moves threaten steep price cuts.
[ Load more ]